Paper · 41150737
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 55
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37193722 | Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers. | Sci Rep | 2023 | https://conductscience.org/library/papers/37193722 | PubMed |
| 2 | 38126031 | Trial watch: beta-blockers in cancer therapy. | Oncoimmunology | 2023 | https://conductscience.org/library/papers/38126031 | PubMed |
| 3 | 32436935 | β-Blocker use is not associated with improved clinical outcomes in women with breast cancer: a meta-analysis. | Biosci Rep | 2020 | https://conductscience.org/library/papers/32436935 | PubMed |
| 4 | 26874901 | Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet Oncol | 2016 | https://conductscience.org/library/papers/26874901 | PubMed |
| 5 | 29936294 | Serotonin and human cancer: A critical view. | Biochimie | 2019 | https://conductscience.org/library/papers/29936294 | PubMed |
| 6 | 35243626 | Contribution of adrenergic mechanisms for the stress-induced breast cancer carcinogenesis. | J Cell Physiol | 2022 | https://conductscience.org/library/papers/35243626 | PubMed |
| 7 | 35300360 | Drug-like Properties and Fraction Lipophilicity Index as a combined metric. | ADMET DMPK | 2021 | https://conductscience.org/library/papers/35300360 | PubMed |
| 8 | 30174436 | The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/30174436 | PubMed |
| 9 | 29935594 | Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. | Br J Anaesth | 2018 | https://conductscience.org/library/papers/29935594 | PubMed |
| 10 | 20332211 | Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line. | Mol Cancer Res | 2010 | https://conductscience.org/library/papers/20332211 | PubMed |
| 11 | 26768715 | Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line. | Curr Drug Discov Technol | 2015 | https://conductscience.org/library/papers/26768715 | PubMed |
| 12 | 2168286 | Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. | Cancer Res | 1990 | https://conductscience.org/library/papers/2168286 | PubMed |
| 13 | 30542705 | β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms. | Oncol Rep | 2019 | https://conductscience.org/library/papers/30542705 | PubMed |
| 14 | 27049669 | Small-Molecule Target Engagement in Cells. | Cell Chem Biol | 2016 | https://conductscience.org/library/papers/27049669 | PubMed |
| 15 | 23912488 | The role of adrenergic signaling in breast cancer biology. | Cancer Biomark | 2013 | https://conductscience.org/library/papers/23912488 | PubMed |
| 16 | 37264315 | Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37264315 | PubMed |
| 17 | 35626710 | Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance. | Cells | 2022 | https://conductscience.org/library/papers/35626710 | PubMed |
| 18 | 36300620 | KEGG for taxonomy-based analysis of pathways and genomes. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/36300620 | PubMed |
| 19 | 21632503 | Beta blockers and breast cancer mortality: a population- based study. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21632503 | PubMed |
| 20 | 31178382 | Beta-blockers: Historical Perspective and Mechanisms of Action. | Rev Esp Cardiol (Engl Ed) | 2019 | https://conductscience.org/library/papers/31178382 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/41150737/references